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Abstract: The mechanical and biological properties of bone implants need to be optimal to 
form a quick and firm connection with the surrounding environment in load bearing 
applications. Bone is a connective tissue composed of an organic collagenous matrix, a fine 
dispersion of reinforcing inorganic (calcium phosphate) nanocrystals, and bone-forming 
and -degrading cells. These different components have a synergistic and hierarchical 
structure that renders bone tissue properties unique in terms of hardness, flexibility and 
regenerative capacity. Metallic and polymeric materials offer mechanical strength and/or 
resilience that are required to simulate bone tissue in load-bearing applications in terms of 
maximum load, bending and fatigue strength. Nevertheless, the interaction between 
devices and the surrounding tissue at the implant interface is essential for success or failure 
of implants. In that respect, coatings can be applied to facilitate the process of bone healing 
and obtain a continuous transition from living tissue to the synthetic implant. Compounds 
that are inspired by inorganic (e.g., hydroxyapatite crystals) or organic (e.g., collagen, 
extracellular matrix components, enzymes) components of bone tissue, are the most 
obvious candidates for application as implant coating to improve the performance of bone 
implants. This review provides an overview of recent trends and strategies in surface 
engineering that are currently investigated to improve the biological performance of bone 
implants in terms of functionality and biological efficacy. 
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Coatings 2012, 2 96 
 
 
Keywords: inorganic; organic; composites; plasma spray; surface modifications; bone; 
implants; coating techniques 
 
1. Introduction 
The use of medical implants has expanded dramatically during the past decades owing to increased 
life-expectancy, changing lifestyles and improved implant technology. Problems related to orthopedic, 
oral and maxillofacial disorders annually affect millions of patients that need a long-term solution to 
regain a high quality of life. Diseases and problems caused by damaged or diseased bone tissue 
represent an annual cost that now exceeds 40 billion Euro worldwide [1]. Nevertheless, the rapid 
increase in the number of elderly people and the corresponding growth of the world population  
require that tissues and organs endure longer and are also able to perform in compromised health 
conditions [2]. 
The musculoskeletal system has structural, protective and mechanical functions. Consequently, in 
order to develop functional replacements for diseased/malfunctioning joints or bone-anchored 
elements (like teeth), extensive and multidisciplinary knowledge on bone healing is required. The 
emergence of modern biology has provided novel insights into the biological mechanisms that are 
responsible for bone healing which currently facilitates the development of artificial implants that 
interact optimally with bone tissue [3]. 
The present review provides an overview of the requirements for bone implants and the approaches 
that are currently investigated to increase their performance by means of surface modifications. Both 
physical and chemical surface modifications are being discussed to transform passive inert implants 
into smart implant surface that actively instruct the physiological environment towards regeneration of 
bone tissue. 
2. Bone Implants 
2.1. Implants: Interface between Living Tissue and Dead Matter 
Bone is a natural and highly hierarchical structured organic-inorganic composite material made of 
collagen fibrils hardened with interspersed hydroxyapatite (HA) nanocrystals. Bone is one of the very 
few human tissues that contains an inorganic phase for mechanical reinforcement. 
The skeletal system is responsible for the support, movement, and protection of the internal organs. 
During activities such as walking and chewing, heavy loads are transferred towards bone tissue which 
means that artificial implants need to be load-bearing. Cycles of chewing, for example, are estimated 
to be of the order of 1 × 105 cycles a year with an average force of 700 N [4,5]. The mechanical 
properties of bone tissue are maintained through a continuous remodeling process of bone formation 
and resorption (bone turnover) that is regulated by “Wolff’s Law”: 
“Bone is deposited and reinforced at areas of greatest stress” [6]. 
The cells which are responsible for tissue remodeling are osteoblasts (bone-forming) and 
osteoclasts (bone-resorbing) [3]. Once a material is introduced into bone tissue, a foreign body 
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response is initiated in the surrounding tissue. In more detail, this response consists of the following 
phases: injury, blood-material interactions, blood clot formation, inflammatory responses, granulation 
tissue development, and tissue remodeling. Bone tissue can be formed directly at the implant surface 
of certain bone-bonding materials without the formation of surrounding fibrous tissue capsules, 
whereas synthetic materials are generally encapsulated upon implantation in soft tissue. During a 
foreign body response, the local biological environment is different from the healthy tissue since this 
foreign body response results into elevated concentrations of reactive oxygen species, proteolytic 
enzymes, fibrotic proteins, giant cells and reduced pH values near the implant surface. As a result, this 
altered environment has a strong effect on implanted materials, which means that this initial  
biological response should be the starting point for design of novel implant surfaces with improved 
functionality [7]. 
2.2. Material Requirements for Load-Bearing Bone Implants 
Metals are applied as biomaterials for bone substituting applications due to their superior 
mechanical performances. The elastic modulus of cortical bone ranges from 10 to 20 GPa [4,8,9], 
which is considerably lower compared to values of metallic biomaterials that are conventionally used 
for load-bearing applications such as titanium and stainless steel which exhibit elastic moduli of about  
118 GPa [10] and 206 GPa [11], respectively. Besides elasticity, fatigue properties are also crucial for 
optimal performance of permanent bone implants. The strong resistance to fatigue is an additional 
factor which has prompted the use metals in load bearing applications. 
The transmission of load between the artificial implant and host tissue is crucial to ensure anchoring 
of bone implants in bone tissue. Load distribution at the interface between a load-bearing bone implant 
and natural tissue is strongly affected by the differences in elastic modulus and mechanical strength. A 
mismatch in stiffness between implants and bone tissue, for example, can cause severe bone resorption 
due to the reduction of stress from bone tissue. This phenomenon, known as stress shielding [4], can 
have severe consequences that compromise the success of bone implants. A material that can achieve a 
strong fixation between bone tissue and the implant surface can transfer the load and the stress from 
the implant to the surrounding bone tissue, thereby ensuring sufficient bone density and strength [12]. 
In addition to its mechanical performance, synthetic materials that are implanted in bone tissue need 
to be non-toxic, non-immunogenic, non-thrombogenic, and non-carcinogenic [13]. In that respect, 
titanium and its alloys have become preferred materials due to their high specific strength, low elastic 
modulus which matches with the elastic modulus of bone tissue, and most of all, their capacity to  
form a thin but very stable oxide layer (i.e., passivation) on the surface which is responsible for its 
inertness [14]. 
Although bio-inertness can be considered as a beneficial property for load-bearing implant surfaces, 
the advent of regenerative medicine has resulted into a paradigm shift with respect to the concept of 
biocompatibility. As a result, the importance of surface modifications has increased considerably. In 
1987, biocompatibility was defined as “the ability of a material to perform with an appropriate host 
response in a specific situation” [13]. During the following two decades, however, the concept of 
biocompatibility has shifted continuously resulting into changing design criteria for novel implant 
materials. As a consequence, surface properties of implants have gained importance since artificial 
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implants are exposed to the surrounding tissue at the material surface. As a result, implants are 
currently designed from a bio-inspired rather than a technologically inspired perspective 
2.3. From Passive to Active Bone Implant Surfaces 
As described above, modifications of bone implant surfaces have received increasing research 
interest in order to orchestrate the physiological healing process and obtain biologically active 
materials that provide biological cues towards tissue regeneration. The ability to target and trigger 
specific responses and recruit the correct type of cells or stimulate them to perform optimally requires 
additional functionality of the bone implant surface. The deposition of coatings allows modifying the 
surface of a material to evoke preferred biological responses, including the reduction of non-specific 
protein adsorption and immobilization of compounds that encourage specific interactions with cells. 
Such coatings can be made of materials that degrade in a controllable manner over time without 
compromising the bulk properties of the device, thereby obtaining a modulated response that 
transforms a material from passive to active. Recently, Williams stressed the bioactive role of 
materials as described above by defining biocompatibility as [13,15] “the ability of a biomaterial to 
perform its desired function with respect to a medical therapy, without eliciting any undesirable local 
or systemic effects in the recipient or beneficiary of that therapy, but generating the most appropriate 
beneficial cellular or tissue response to that specific situation, and optimizing the clinically relevant 
performance of that therapy”. 
In the current review, the term “passive” refers to implants that are not chemically or biologically 
reactive and present rather inert surfaces to the surrounding tissues, whereas the term “active” refers to 
implants that have been modified to deliberately interfere with the physiological environment by 
providing biological cues that trigger specific responses. 
2.4. Surface Modifications for Bone Implants 
Surfaces of bone implants represent the site of interaction with the surrounding living tissue and are 
therefore crucial to enhance the biological performance of implants [16,17]. Surface engineering aims 
to design implants of improved biological performance which are able to modulate and control the 
response of living tissue. Generally, surface engineering includes modification of topographical  
(i.e., roughness) and chemical (i.e., coating) characteristics of a medical device. Topographical 
modifications of titanium and its alloys were aimed at increasing the roughness of implant surfaces, 
thus increasing the surface area of implants compared to larger smooth surfaces. The increased surface 
area increases cell attachment and augments the biomechanical interlocking between bone tissue and 
the implant. To this end, several techniques have been developed, including grit-blasting and acid 
etching. Grit-blasting is obtained by bombardment of implant surfaces by means of silica (also known 
as sand-blasting), hydroxyapatite, alumina or TiO2 particles. Acid-etching treatments are generally 
performed using hydrofluoric, nitric, or sulphuric acid. A detailed analysis of topographical 
modification of implants and its relevance for commercial applications has been performed by  
Dohan Ehrenfest et al. [18]. Recently, the emergence of nanotechnology has expanded the scope of 
topographical modifications from the micro- to nanoscale, thereby affecting cells, biomolecules and 
ions at the nanoscale. Nanotechnology is the field that focuses on synthesis, characterization and 
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application of materials with at least one dimension sized between 1 and 100 nm. Recently, this 
nanoscale dimension has received increasing interest in the field of surface engineering, e.g., by 
developing coatings of thickness below 100 nm or using nanoparticles or nanocrystals with dimensions 
smaller than 100 nm as components for nanostructured coatings [19]. 
Surface modifications based on the deposition of coatings retain the mechanical properties of 
titanium while the functionality of the implant surface can be upgraded by application of (bio)chemical 
compounds that act as cues towards improved bone regeneration. Upon successful immobilization of 
these compounds onto implant surfaces, the substrate is responsible for the load-bearing function of 
the implant whereas the coating should facilitate optimal integration into the surrounding tissues. 
3. Surface Engineering: Coating Deposition  
3.1. Biological Activity of Bone Implant Coatings 
The biological response to implanted bone implants is time-dependent and should ultimately result 
into complete integration of the artificial implant within the native bone tissue. The initial 
inflammatory response that follows implant installation determines subsequent remodeling phases in 
the process of bone healing that lead to transfer of mechanical forces and the high degree of 
organization of functional bone tissue [20]. Biocompatibility and osteoconductivity of the implant are 
generally recognized as main success factors for satisfactory long-term performance endosseous 
implants [21]. 
Every bone implant is recognized by human tissues as a foreign body [13,22,23]. For this reason the 
main aim of coating development until two decades ago was to avoid or limit this foreign body 
response since an excessive foreign body response creates an intermediate layer of collagenous fibrous 
tissue in between the material surface and the hosting tissue [22,23]. This fibrous capsule will 
ultimately result into loss of implant function and ultimately implant loosening. Coatings can be 
applied onto bone implants to avoid soft tissue formation and create a strongly integrated and 
interlocked transition between tissue and the implant surface, a phenomenon that is called 
osteointegration. According to the European Society of Biomaterials, during the consensus conference 
of 1987, a material can be defined bioactive if it is “one which has been designed to induce specific 
biological activity”. For materials implanted in bone tissue, bioactive materials correspond to implants 
that induce a direct bond between the implant surface and the surrounding bone tissue.  
Summarizing, the primary aim of engineering bone implant surfaces is to positively modulate the 
interfacial response between the implant and host tissue. For this purpose, numerous surface 
engineering methods have been introduced in the last four decades to change surface topography and 
chemistry of endosseous dental implant. Junker et al. has systematically reviewed the efficacy of a 
wide variety of surface modifications including roughening of dental implants as well as applications 
of inorganic (calcium phosphate) or organic (adhesion peptides, growth factors) coatings. An overview 
of the most extensively used topography modifications of commercially available dental implants is 
reported in Table 1. The following sections will discuss current trends in surface engineering based on 
inorganic, organic and composite coatings. 
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Table 1. Overview of commercially available surface modifications (topography) for 
dental implants. 
Name Description 
OsseoSpeed (Astra Tech AB, 
Mölndal, Sweden) 
Titanium oxide blasting followed by chemical modification of the 
surface by hydrofluoric acid treatment 
SLActive (ITI; Institute Straumann, 
Waldenburg, Switzerland) 
Coarse grit-blasting with 0.25–0.5 mm aluminum oxide grit at 5 bar 
followed by acid etching 
TiUnite (Nobel Biocare Holding 
AG, Zürich, Switzerland) 
Electrochemical anodization process 
Nanotite (3i Implant Innovations, 
Palm Beach Gardens, FL, USA) 
Sol-gel deposition 
Friadent plus (Dentsply Friadent, 
Mannheim, Germany) 
large grit blasting (354–500 μm) and acid etching in hydrochloric 
acid/sulfuric acid/hydrofluoric acid/oxalic acid 
Ossean (intra-Lock, Boca-Raton, 
FL, USA) 
is a grit-blasted/acid-etched/calcium phosphate impregnated surface 
3.2. Trends in Material for Inorganic Coatings on Bone Implants 
In bone tissue, the inorganic phase is mainly composed of carbonate-rich hydroxyapatite. 
Consequently, hydroxyapatite ceramics have always been an obvious candidate for deposition as 
coating onto bone implant surfaces. These hydroxyapatite coatings were shown to be bioactive and 
stimulate the formation of new bone tissue in numerous pre-clinical and clinical studies [24–28]. 
Chemical parameters such as the Ca/P ratio, phase composition and crystal structure have been 
evaluated and tested extensively to optimize the performance of CaP coatings. HA coatings showed a 
persistent significant improvement of the osteoconductivity of metallic implants [29–35].  
During the past two decades, recent trends in research on calcium phosphate (CaP) coatings  
mainly focused on modification of its chemical structure and addition of ionic dopants. Currently, 
several types of CaP-based coatings have been explored such as pure HA [36–44], Si-containing HA 
(Si-HA) [31,40,45–52], Sr-doped HA [53–56], Mg-substituted HA [47], bisphosphonate and  
HA [55,57], carbonated HA [32,47,58], fluorinated HA [44,59–61] and antibacterial Ag-containing 
HA (Ag-HA) [62–67]. 
3.3. Trends in Material for Organic Coatings on Bone Implants 
Over the past two decades, organic compounds derived from the extracellular matrix (ECM) of 
bone issue are increasingly considered as source of inspiration for bioinspired design of organic bone 
implant coatings [68]. 
Different approaches can be used to upgrade a bone implant from a passive medical device to an 
instructive implant that can solicit a desired tissue response [69–73] using organic biomolecules. 
Organic surface modifications that are currently investigated involve immobilization of among others 
structural proteins, signaling molecules, enzymes or peptides onto biomaterial surfaces to target cell 
response at the tissue-implant interface [74,75].  
A widely investigated approach aims at improving the adhesion of cells onto bone implant  
surfaces. ECM biomolecules such as fibronectin, vitronectin, type I collagen, osteopontin, and bone 
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sialoprotein [76] have been successfully immobilized onto bone implants. These proteins exerted 
biological effects upon immobilization onto surfaces, but the tendency of proteins to fold upon 
adsorption to an implant surface remains problematic and decreases the efficacy of immobilized 
proteins. However, short peptide sequences derived from entire proteins can overcome this  
problem [77]. Surface-immobilized peptide sequences can recruit or trigger specific cellular 
interactions [77,78]. The peptide sequence that has been investigated most extensively so far is the 
Arg-Gly-Asp (RGD) peptide sequence which is the predominant binding site for cells via integrin 
receptors RGD sequence [79,80], but various other peptide sequences have been used similarly onto 
implanted materials [81–84]. 
Alternatively, osteotropic biomolecules such as growth factors (GFs) can be immobilized onto 
implant surfaces. Several GFs, including bone morphogenetic protein (BMP), transforming growth 
factor-beta (TGF-β), fibroblast growth factor (FGF), platelet-derived growth factor (PDGF), and 
insulin-like growth factor (IGF), have been shown to stimulate formation of bone tissue around 
implants upon immobilization onto their surface. Most emphasis, however, has been put on the 
immobilization of members of the TGF-β superfamily such as BMP-2, BMP-7 and TGF-β1, which 
have shown promising results in enhancing bone formation around bone implants [85–87]. 
Besides targeting cellular behavior directly, organic biomolecules such as collagen can also improve 
mechanical properties of surface coatings while biomolecules such as osteopontin, osteonectin, bone 
sialoprotein, osteocalcin, or alkaline phosphatase have been investigated as initiators of mineralization 
by deposition of calcium phosphate onto implant surfaces. For example, immobilized alkaline 
phosphatase was shown to induce deposition of apatitic mineralization layers in vitro and new bone 
formation in vivo [68,88]. 
3.4. Trends in Materials for Composite and Combined Coatings on Bone Implants 
Since bone is a composite tissue, deposition of composite coatings consisting of inorganic and 
organic constituents is an obvious next step towards design of implant coatings with improved 
bioactivity and efficacy.  
For example, composite coatings composed of collagen and CaP minerals could combine the 
benefits of the mineral phase (in terms of osteoconduction) and the collagenous matrix (in terms of 
abundance of RGD-sequences) to affect cellular adhesion, subsequent proliferation, and differentiation 
phases [89,90]. In addition to the biological effects of collagen [91], CaP-collagen composite coatings 
showed an improved retention of CaP crystals onto implant surfaces [92,93]. 
Also growth factors have been co-deposited with calcium phosphate or collagen coatings onto 
implant surfaces [87,94–97]. In fact, GFs immobilized on titanium implants pre-coated with collagen 
showed increased osteogenic properties compared to GFs bound to untreated titanium surfaces [98,99]. 
This may be due to a sustained delivery profile or a higher stability of the growth factor [94,100,101]. 
Infections during or after surgery still remain a big threat that can compromise the short- and  
long-term stability of orthopedic implants [102,103]. Therefore, antibiotics have also been loaded into 
CaP coatings onto titanium implants [104]. The coated antibiotic-HA-composite exhibited a reduced 
infection rate compared with CaP coatings in vivo [105]. In order to reduce the risk of antibiotic 
resistance also non-antibiotic organic compounds with antimicrobial activity like chlorhexidine, 
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chloroxylenol, and poly(hexamethylenebiguanide) [106–112] have been investigated as potential 
alternatives. These organic molecules are commonly used for their broad spectrum of antimicrobial 
action and lower risk of drug resistance. 
Composite coatings can also be prepared by incorporating antimicrobial elements such as silver 
ions into organic or inorganic coatings since bacterial resistance against silver is minimal [113]. 
Finally, bone implants are often applied in patients of compromised health. Post-menopausal 
osteoporosis, for example, reduces bone density resulting into higher prevalence of bone fractures. The 
use of a local active compound for the prevention or reduction of these osteoporotic fractures could 
improve the efficacy and fixation of bone implants into osteoporotic bone. Bisphosphonates (BPs) are 
a group of synthetic drugs with a structural backbone similar to inorganic pyrophosphate with a 
general structure of PO3-C-PO3. BPs have been used, for long times, for the treatment of skeletal 
metabolism disorders such as osteoporosis, Paget’s disease, tumor-associated osteolysis and 
hypercalcemia [114–116]. BPs act by reducing osteoclasts (bone resorbing cells) activity but  
systemic delivery of BPs by oral administration or intravenous injection is associated with serious 
side-effects [117,118]. The affinity of BPs for HA has been used to develop new CaP-BP composite 
coating systems for the controlled release of BP from bone implants [119–121]. The reduced activity 
of bone resorbing cells induced an improved mechanical interlocking of the implant with the hosting 
bone tissue and correspondingly a faster recovery from surgery [122].  
4. Coating Techniques  
In order to improve surfaces properties, innovative coating compounds only are not sufficient. 
Techniques and technology used to deposit these substrates onto implants surfaces have witnessed a 
constant evolution during the past decades. Calcium phosphate are the largest group of materials used 
for coating deposition, for which several types of deposition techniques have been investigated 
including dip and immersion coating, electrophoretic deposition, laser deposition, thermal spraying 
(including plasma spraying and high-velocity oxy-fuel combustion spraying), biomimetic deposition 
and sol-gel deposition [123]. Characteristics of several commonly used coating techniques including 
their advantages, limitations and precursors used are summarized in Table 2. 
4.1. Dry Deposition Techniques 
Among all the coating techniques that have been investigated for deposition of CaP coatings, 
physical coating techniques are the ones that most often reached the commercial market. These 
physical coating techniques, such as plasma-spraying, radio frequency magnetron sputtering, pulsed 
laser deposition (PLD) and ion beam assisted deposition (IBAD) have been used to deposit several 
types of CaPs. The most widespread method to deposit CaP coatings onto implants is the plasma-spraying 
technique mainly due to its high deposition rate and the possibility to cover large areas. 
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Table 2. Overview of characteristics of coating techniques. 
Technique 
Coating 
thickness 
Advantage Disadvantage Precursor materials 
Plasma spraying 50–250 μm High deposition rates Non-uniform coating crystalinity; line 
of sight technique 
HA [36,124–128], Si-HA [40,49] and antibacterial 
Ag- HA composite coatings [66,67,129] 
RF magnetron sputtering 0.5–5 μm Uniform and dense coating; 
strong adhesion 
Line of sight technique; time 
consuming; low deposition rates 
HA [43], Si-HA [48,52], carbonated HA [32], and 
Zn, Mg, and Al-doped CaPs [130] 
Plasma spraying 50–250 μm High deposition rates Non-uniform coating crystalinity; line 
of sight technique 
HA [36,124–128], Si-HA [40,49] and antibacterial  
Ag-HA composite coatings [66,67,129] 
Pulsed laser deposition 0.05–5 μm Control over coating chemistry 
and morphology 
Line of sight technique 
HA resistant to dissolution in SBF [29], Ag-HA 
[131,132], HA [133–140] and fluorinated HA [60] 
alendronate-doped HA [57] 
Ion beam dynamic mixing 
deposition 
0.05–1 μm High adhesive strength Line of sight technique; requires high 
sintering temperatures 
CaP coatings [141–147] 
Ion beam assisted 
deposition 
0.02–10 μm increased tensile bond strength Line of sight technique; CaP [31,148–150] 
Biomimetic deposition <30 μm Coating of complex geometries; 
co-deposition of biomolecules 
Time consuming; requires controlled 
pH 
osteocalcin [151], fibronectin [152] and  
poly(L-lysine) [153]. BMP-2 incorporated into 
biomimetic CaP coatings [154,155]. 
Sol-gel deposition <1 μm Coating of complex geometries; 
low processing temperature 
Requires controlled atmosphere 
processing; expensive raw materials 
aluminosilicate [156], fluoridated hydroxyapatite, 
[157] Si-substituted hydroxyapatite [158], and 
bioglass [159–161] 
Electrophoretic deposition 0.1–2 mm 
Uniform coating; coating of 
complex geometries; high 
deposition rates 
Difficult to produce crack-free 
coatings; low adhesive strength 
CaP-chitosan composite coatings successfully 
combined with CaSiO3, heparin, and silica  
[162–164] 
Electrospray deposition 0.1–5 μm 
Co-deposition of biomolecules; 
control over coating 
composition and morphology 
Low mechanical strength; Line of 
sight technique 
HA [165,166],Nano HA [167], ALP [168], 
biomolecules-HA composite [88] collagen [169] 
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The plasma-spraying (PS) technique involves the introduction of precursor materials 
(feedstock)into the hot plasma jet (Figure 1) generated by a plasma torch [31,170], at atmospheric 
pressure (Atmospheric Plasma Spraying, APS), under vacuum (Vacuum Plasma Spraying, VPS) or 
under reduced pressure (Low Pressure Plasma Spraying, LPS) [171–179]. As a consequence, upon 
impingement of feedstock powders particles onto the implant surface, an adherent coating is formed 
due to partial or complete melting of the powder particles.  
Figure 1. Schematic representation of a Radio Frequency (RF) plasma torch. 
 
Another physical technique that is often used to deposit strongly adherent HA onto implants is 
Radio Frequency (RF) magnetron sputtering (Figure 2) [180–184]. Sputtering is a process whereby 
atoms or molecules of some materials are ejected in a vacuum chamber, becoming precursors for 
coating, due to bombardment with high-energy ions [31,185]. 
Figure 2. Schematic representation of RF magnetron sputtering. 
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Pulsed laser deposition (PLD) is a physical vapor deposition technique that was first described by 
Cotell [186] to deposit thin films of CaP [55,132,138,187–191]. The PLD system (Figure 3) is 
typically composed of a KrF laser source, an ultrahigh vacuum deposition chamber equipped with a 
rotating target and a fixed substrate holder plus pumping systems. The PLD process involves the 
irradiation of a solid target by a focused pulsed laser and this interaction creates compounds such as 
Ca4P2O9, Ca3(PO4)2, CaO, P2O5, and H2O [29]. This high energy plasma cloud is composed of 
electrons, atoms, ions, molecules, molecular clusters and, in some cases, droplets and target fragments. 
This plasma cloud expands, either in vacuum or in a gaseous environment, and deposits on a substrate, 
typically with a temperature in the range of 350–600 °C, producing a thin adherent film onto the  
target [192]. An alternative set-up called matrix assisted pulsed laser evaporation (MAPLE) was 
developed for delicate and accurate deposition of both organic and inorganic materials [133]. 
Figure 3. Schematic representation of the pulsed laser deposition (PLD) coating system. 
 
Ion beam assisted deposition (IBAD) is a vacuum technique that has also been used to deposit very 
thin ceramic coating layers on metals, polymers or ceramics. A typical IBAD system consists of two 
main elements: electron or ion bombarded precursor materials that vaporize forming an elemental 
cloud that covers the surface of a substrate [31,148–150] as well as an ion gun that irradiates the 
substrate with highly energetic gas ions that can be inert like Ar+ or reactive like O2+ to induce 
adhesion of the precursors from the above-mentioned elemental cloud [149].  
All these physical deposition techniques, however, are highly energetic to achieve a strong fixation 
of the coating on the surface. This energy (plasma, laser or ions bombardment) involves high 
temperature that can reach, in some cases, up to 2000 °C [193,194]. Increased temperature during 
deposition facilitates a firm fixation of the coating onto the surface but it limits the selection for 
materials that can be coated. Organic materials and biomolecules cannot be deposited using these 
physical techniques and crystallinity of precursor phases are affected by the thermal process which 
impedes deposition of biologically relevant CaPs such as carbonate-substituted apatites. 
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4.2. Wet Deposition Techniques 
Wet chemical deposition methods such as biomimetic and sol-gel are alternatives to physical 
deposition techniques which allow for preservation of biomolecules activity. These techniques have 
strong advantages related to their simple experimental setup, mild chemical preparation conditions and 
the possibility to coat implants with a complex three-dimensional geometry (such as porous implants). 
Such implants cannot be coated using physical coating techniques due to their line-of-sight 
characteristics. In a recent review by Nijhuis et al. [75], an overview is given of current trends in wet 
chemical deposition of biomedical coatings for bone substitution.  
The biomimetic deposition method was introduced for the first time by Kokubo et al. in 1990 and is 
formed under physiological conditions (37 °C, pH 7.4, p(CO2) = 0.05 atmosphere and appropriate 
electrolyte concentrations) [195]. The system involves simple immersion of (pretreated) Ti substrates 
into a so-called simulated body fluid (SBF) to obtain deposition of a biologically active bone-like CaP 
layer formed onto the surface of the substrates. 
The sol-gel technique is based on colloidal suspensions of solid particles (1–500 nm in size) in a 
liquid solution (a sol). The sol can be applied onto the substrate via different methods like spin-coating, 
spraying, or dip-coating. The coating, still in gel form, is put on the target surface and after drying only 
the precursor materials, through the sol-gel transition, are left as a thin layer [196,197] 
4.3. Electrochemical Deposition Techniques 
In order to combine the advantage of physical deposition (in terms of quantity control) and  
wet chemical deposition (non-aggressive setting) electrochemical deposition methods have been 
advocated. These types of coating depositions can be performed at ambient temperature and pressure 
provided that precursors are particles or molecules that carry an electrical charge or that can be dispersed in 
electrolytic solutions. The substrates, onto which the coating is applied, also need to be conductive. 
Electrophoretic deposition, for instance, is a technique based on migration of precursor particles 
suspended in liquid towards substrate surfaces under the influence of an externally applied electrical 
field. The medium used for electrophoretic deposition is made of organic solvents such as isopropanol 
or ethanol [198,199]. This technique is a submersion method and so it allows for coating of, e.g., 
porous implants. 
Another promising electrochemical coating system is the electrospray deposition (ESD) technique. 
Using this technology solutions or suspensions containing precursor materials are sprayed onto 
substrates under the influence of a high electrical field that creates an aerosol of similarly charged 
micron-sized droplets [200,201]. ESD allows for a strong control over physicochemical coating 
properties such as thickness or chemical composition. 
4.4. Clinical Performance 
Over the past two decades, the application of treatments such as gritblasting and acid etching has 
become widely accepted as routine topographical treatment for oral implants, as evidenced by 
numerous commercial implant systems that are being marketed after, e.g., a combination of 
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gritblasting and acid etching. An overview of surface modification of oral implants that are 
commercially available is shown in Table 1. 
Regarding the application of additional coatings it should be stressed that despite extensive research 
efforts only a limited amount of techniques have made it to clinical trials and commercialization (mainly 
PS, RF magnetron sputtering and IBAD), whereas most of the other techniques (such as biomimetic 
deposition, electrospray deposition, etc.) are still in the pre-clinical phase. In most cases, adhesion, 
cost-effectiveness and high costs related to industrial upscaling were the determining factors that 
limited widespread use and market penetration of various novel surface engineering techniques so far. 
5. Summary and Future Perspectives 
Since the application of plasma-sprayed hydroxyapatite coatings onto metallic bone implants in the 
1980s, the concept of bone implant coatings has shifted from passive protecting thin films to active 
and instructive immobilized layers. Nowadays, a plethora of coating techniques is being investigated 
to actively orchestrate a desired biological response at the interface between artificial implants and the 
surrounding living tissue. In view of the aging population and changing lifestyle, surgeons will be 
confronted with an increasing number of patients of compromised health that need implants of higher 
efficacy than currently available.  
To this end, bone implant surfaces will be increasingly enriched with biomolecules to accelerate the 
bone healing process. For this purpose, a wide variety of biomolecules such as growth factors, bioactive 
proteins, enzymes, and non-viral genes (DNAs, RNAs) is currently being evaluated pre-clinically.  
For optimal therapeutic efficacy, the fate of these biomolecules needs to be controlled, i.e. efficient 
immobilization strategies need to be developed for covalent or non-covalent immobilization. 
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